We are live on ! Find out more
CC

Cannell & Co Portfolio holdings

AUM $3.15B
1-Year Est. Return 30.62%
This Fund
S&P 500
This Quarter Est. Return
+5.25%
1 Year Est. Return
+30.62%
3 Year Est. Return
+51.59%
5 Year Est. Return
+187.25%
10 Year Est. Return
+311.51%
AUM
$2.91B
AUM Growth
+$22.1M
Cap. Flow
-$74.9M
Cap. Flow %
-2.58%
Top 10 Hldgs %
28.1%
Holding
260
New
19
Increased
62
Reduced
99
Closed
10

Top Buys

1
QCOM icon
Qualcomm
QCOM
+$58.9M
2
BKI
Black Knight, Inc. Common Stock
BKI
+$47.2M
3
ULTA icon
Ulta Beauty
ULTA
+$39.2M
4
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
+$36M
5
LUV icon
Southwest Airlines
LUV
+$15M

Top Sells

1
FNF icon
Fidelity National Financial
FNF
+$77.7M
2
TOL icon
Toll Brothers
TOL
+$33M
3
CCEP icon
Coca-Cola Europacific Partners
CCEP
+$28.6M
4
BHC icon
Bausch Health
BHC
+$21.5M
5
AGN
Allergan plc
AGN
+$19.4M

Sector Composition

1 Technology 18.24%
2 Healthcare 18.14%
3 Industrials 15.39%
4 Financials 12.06%
5 Consumer Discretionary 11.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GDXJ icon
226
VanEck Junior Gold Miners ETF
GDXJ
$6.64B
$311K 0.01%
9,125
– –
AVEO
227
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$307K 0.01%
10,988
– –
SKT icon
228
Tanger
SKT
$4.8B
$297K 0.01%
11,200
– –
PGC icon
229
Peapack-Gladstone Financial
PGC
$820M
$286K 0.01%
8,171
– –
MCS icon
230
Marcus Corp
MCS
$695M
$276K 0.01%
10,100
– –
LSXMK
231
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
$265K 0.01%
8,765
-1,313
-13% -$41.6K
JHG
232
DELISTED
Janus Henderson
JHG
$249K 0.01%
6,509
– –
HES
233
DELISTED
Hess
HES
$242K 0.01%
5,100
-75
-1% -$3.38K
TROW icon
234
T. Rowe Price
TROW
$25.1B
$241K 0.01%
2,300
– –
BUD icon
235
AB InBev
BUD
$157B
$240K 0.01%
2,150
-400
-16% -$47.1K
VRTX icon
236
Vertex Pharmaceuticals
VRTX
$124B
$238K 0.01%
1,588
– –
ENLC
237
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
$238K 0.01%
13,500
– –
MTB icon
238
M&T Bank
MTB
$36.5B
$231K 0.01%
+1,352
New +$224K
AEP icon
239
American Electric Power
AEP
$73.1B
$212K 0.01%
2,881
+24
+0.8% +$1.79K
YTEN
240
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
$208K 0.01%
122
+46
+61% +$124K
LHX icon
241
L3Harris
LHX
$53.4B
$204K 0.01%
+1,439
New +$201K
UAA icon
242
Under Armour
UAA
$3.18B
$202K 0.01%
14,000
– –
A icon
243
Agilent Technologies
A
$37.4B
$200K 0.01%
2,990
-365
-11% -$24.6K
UA icon
244
Under Armour Class C
UA
$3.1B
$188K 0.01%
14,098
– –
IMBI
245
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
$70K ﹤0.01%
5,000
– –
EMMA
246
DELISTED
Emmaus Life Sciences, Inc. Common Stock
EMMA
$68K ﹤0.01%
3,333
– –
RIBT
247
DELISTED
RiceBran Technologies
RIBT
$63K ﹤0.01%
4,241
– –
GNMK
248
DELISTED
GenMark Diagnostics, Inc
GNMK
$42K ﹤0.01%
10,000
– –
KOPN icon
249
Kopin
KOPN
$687M
$35K ﹤0.01%
11,000
– –
MYNDW
250
DELISTED
MYnd Analytics, Inc. Warrant
MYNDW
$9K ﹤0.01%
20,000
– –
7 8 9
10
11

Similar funds

GW
GW & Wade Wellesley, Massachusetts $3.08B AUM 18.99% 1-Year Est. Return
PMEF
Point72 Middle East FZE Dubai, United Arab Emirates $3.38B AUM 14.09% 1-Year Est. Return
SS
Simplicity Solutions Minneapolis, Minnesota $3.66B AUM 23.51% 1-Year Est. Return
WMSA
Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
WP
WealthSource Partners San Luis Obispo, California $1.54B AUM 16.68% 1-Year Est. Return
BWM
Baystate Wealth Management Boston, Massachusetts $1.36B AUM 15.87% 1-Year Est. Return
DI
DFPG Investments Sandy, Utah $1.28B AUM 27.55% 1-Year Est. Return

Cannell & Co's Q4 2017 Portfolio in Review

As of Q4 2017, Cannell & Co held 260 positions worth $2.91B, up 0.77% from $2.88B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Cannell & Co's Q4 2017 filing shows 19 new, 62 increased, 99 reduced and 10 closed positions. Its largest new stake was Qualcomm: 971,690 shares worth $62.2M. The largest sale was Fidelity National Financial, an estimated $77.7M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 14% a quarter earlier, followed by Healthcare and Industrials.

  • Cannell & Co's largest Q4 2017 buy was Qualcomm: 971,690 shares worth $62.2M.
  • Cannell & Co added most to Royal Dutch Shell PLC ADS Class A in Q4 2017, an estimated $36M increase.
  • Cannell & Co's biggest Q4 2017 reduction was Fidelity National Financial, cutting an estimated $77.7M.
  • Cannell & Co fully exited Bausch Health in Q4 2017, selling an estimated $21.5M.
  • Cannell & Co's ten largest holdings make up 28% of its $2.91B portfolio in Q4 2017.
  • Cannell & Co opened 19 new positions and closed 10 in Q4 2017.
  • Cannell & Co's portfolio value rose 0.77% quarter-over-quarter to $2.91B.

Based on Cannell & Co's 13F filing for Q4 2017, filed 13 Feb 2018.